Tailor-made Antibodies
and Tools for Life Science
Home|||||Technical Support

m6A antibody - 202 008

N6-methyladenosine or m6A are posttranscritional modifications of RNA and DNA
Rabbit monoclonal recombinant IgG
Cat. No.: 202 008
Amount: 100 µg
Price: $415.00
Cat. No. 202 008 100 µg purified recombinant IgG, lyophilized. Albumin and azide were added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
Dot blot: 1 : 1000 up to 1 : 2000 gallery  
IP: yes
ICC: not tested yet
IHC: not tested yet
IHC-P: not tested yet
MeRIP: yes

Immunodetection of target molecules spotted onto a membrane.

Immunoprecipitation (IP); Immunoisolation or pulldown of a target molecule using an antibody. For details and product specific hints, please refer to the ”Remarks” section.

Immunocytochemistry (ICC) on 4% PFA fixed cells. Immunoreactivity is usually revealed by fluorescence. Some antibodies require special fixation methods. For details, please refer to the “Remarks” section.

Immunohistochemistry (IHC) on 4% PFA perfusion fixed tissue with 24h PFA post fixation. Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate. Some antibodies require special fixation methods or antigen retrieval steps. For details, please refer to the ”Remarks” section.

Immunohistochemistry (IHC-P) of formalin fixed, paraffin embedded (FFPE) tissue (some antibodies require special antigen retrieval steps, please refer to the ”Remarks” section). Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate.

Methylated RNA immunoprecipitation (MeRIP) sequencing is an antibody based m6A-mapping method, based on parallel sequencing of immunoisolated RNA fragments (100 -200 nt long) carrying m6A modifications.

Clone Rb212B11
Subtype IgG1 (κ light chain)
Immunogen N6-methyladenosine fused to BSA
Reactivity Reacts with: human, rat, mouse, eukaryotes, prokaryotes.
Other species not tested yet.
Specificity Specific for m6A with some cross-reactivity to m6Am
Remarks

This antibody is a chimeric antibody based on the well known monoclonal mouse antibody clone 212B11. The constant regions of the heavy and light chains have been replaced by rabbit specific sequences. Therefore, the antibody can be used with standard anti-rabbit secondary reagents. The antibody has been expressed in mammalian cells.

Data sheet 202_008.pdf

References for m6A - 202 008

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
Zeng K, Li W, Wang Y, Zhang Z, Zhang L, Zhang W, Xing Y, Zhou C
Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023) 1025: e2301088. 202 008 ICC; tested species: human
Cat. No.: 202 008
Amount: 100 µg
Price: $415.00
Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
Zeng K, Li W, Wang Y, Zhang Z, Zhang L, Zhang W, Xing Y, Zhou C
Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023) 1025: e2301088. 202 008 ICC; tested species: human
Background
m6A (N6-methyladenosine) is a posttranscriptional RNA-modification found throughout all kingdoms, e.g. in vertebrate snRNAs U2, U4, U6, in viral and eukaryotic mRNAs, and in E. coli 16S rRNA.
Recent studies have found that mRNA is predominately m6A modified at stop codons and long internal exons, which are conserved between mouse and human. The so-called RNA methylome probably plays an important role in in the regulation of gene expression.
In E. coli Dam methylase introduces m6A modifications on the DNA level at the 5'-GATC-3' motif. This allows the cell to differentiate between the parental and the daughter strand during mismatch repair.